A pipeline analysis of new products for malaria, tuberculosis and neglected tropical diseases: a working paper

18 August 2016

This working paper provides a comprehensive survey of new medicines, diagnostics and vaccines for malaria, TB and selected NTDs, that are currently in the pipeline for market entry by 2020. Potential challenges and key health system requirements for effective introduction of these products in developing countries are highlighted, as are factors related to supply and pricing, and potential market and competition landscapes. This paper will be updated periodically, and will serve as a valuable resource for policymakers of disease programme implementation and product procurement, contributing towards better planning and informed decision-making for the adoption and introduction of new health products.

Document group
Guidelines / handbooks / toolkits
Download link
Share on